Covaxin offers protection against beta and delta variants, says study
The Hindu
The study was carried out by researchers from National Institute of Virology, ICMR and Bharat Biotech.
A small study claims that from both the delta (B.1.617.2) and beta (B.1.351) variants. Also read: The study evaluated the neutralisation potential in people vaccinated with Covaxin and found that there was a 3- and 2.7-fold reduction in neutralisation titers against the beta (B.1.351) and delta (B.1.617.2) variants, respectively. In comparison, the reduction in neutralisation titers with sera from people who have recovered from COVID-19 were 3.3- and 4.6-fold against the beta and delta variants, respectively. The results of the study were preprint server on June 7. Preprints are yet to be peer-reviewed.More Related News